Get startedLog in
    Picture of Zydus Lifesciences logo

    ZYDUSLIFE — Zydus Lifesciences Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Zydus Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    R2023
    March 31st
    C2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSPRESS
    Standards:
    IAS
    IAS
    IAS
    IAS    		—
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line28,38125,89748,08960,26766,211
    Depreciation
    Non-Cash Items-4,4402,042-1,8821,046-16,978
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-10,520-8,278-21,825-2,538-40,245
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities20,78226,88832,02367,93323,068
    Capital Expenditures-12,026-10,309-9,066-17,126-33,940
    Purchase of Fixed Assets
    Other Investing Cash Flow Items23,57025,659-5,686-66,597-49,021
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities11,54415,350-14,752-83,723-82,961
    Financing Cash Flow Items-1,111-1,262-413-895-3,536
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-8,683-44,004-17,78820,14258,069
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash23,729-1,700-7484,138284